glp-1 stomach paralysis law office in louisiana semaglutide ileus class action louisiana semaglutide bowel obstruction lawyer semaglutide gi obstruction lawyer louisiana Louisiana Ozempic Lawsuit Lawyer louisiana semaglutide stomach paralysis legal

Lilly followed up with lawsuits of its own on June 20 aiming to combat unsafe compounded products. So far, neither Novo nor Lilly appear to have sued Hims

, '

Mikkelsen and N

In another 2025 study by Qeadan and colleagues that used electronic health data from over 1.3 million individuals with a history of alcohol use disorder and opioid use disorder, researchers found that individuals with alcohol use disorder (n=817,309) prescribed GLP-1 medications experienced about 50% fewer alcohol intoxication events over the 2-year period compared to patients who didnt receive the medications (Qeadan et al., 2025)

The overall response rate (ORR) for CM patients to ipilimumab, nivolumab, pembrolizumab and atezolizumab is 12%, 40%, 33% and 30% respectively (167169), while the combined treatment of ipilimumab with nivolumab significantly improves the ORR to 61% with median progression-free survival (PFS) of 11.5 months (170, 171)